145 related articles for article (PubMed ID: 11477138)
21. Mutational analysis of transforming growth factor beta receptor type II and DNA mismatch repair genes in sporadic endometrial carcinomas with microsatellite instability.
Ohwada M; Suzuki M; Saga Y; Suzuki T; Ikeda M; Yamada M; Sato I
Oncol Rep; 2000; 7(4):789-92. PubMed ID: 10854545
[TBL] [Abstract][Full Text] [Related]
22. A functional assay for mutations in tumor suppressor genes caused by mismatch repair deficiency.
Ji HP; King MC
Hum Mol Genet; 2001 Nov; 10(24):2737-43. PubMed ID: 11734538
[TBL] [Abstract][Full Text] [Related]
23. Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability.
Yashiro M; Hirakawa K; Boland CR
BMC Cancer; 2010 Jun; 10():303. PubMed ID: 20565851
[TBL] [Abstract][Full Text] [Related]
24. A novel missense mutation and frameshift mutations in the type II receptor of transforming growth factor-beta gene in sporadic colon cancer with microsatellite instability.
Orimo H; Ikejima M; Nakajima E; Emi M; Shimada T
Mutat Res; 1998 May; 382(3-4):115-20. PubMed ID: 9691992
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
[TBL] [Abstract][Full Text] [Related]
26. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite alterations and K-ras, TGFbetaRII, IGFRII and bax mutations in sporadic cancers of the gastrointestinal tract.
Caligo MA; Ghimenti C; Sensi E; Marchetti A; Bertacca G; Giulianotti PG; Fornaciari G; Bevilacqua G
Oncol Rep; 2000; 7(6):1371-5. PubMed ID: 11032947
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
Lynch MA; Nakashima R; Song H; DeGroff VL; Wang D; Enomoto T; Weghorst CM
Cancer Res; 1998 Oct; 58(19):4227-32. PubMed ID: 9766642
[TBL] [Abstract][Full Text] [Related]
29. Novel mutations in the polyadenine tract of the transforming growth factor beta type II receptor gene are found in a subpopulation of human pancreatic adenocarcinomas.
Venkatasubbarao K; Ahmed MM; Swiderski C; Harp C; Lee EY; McGrath P; Mohiuddin M; Strodel W; Freeman JW
Genes Chromosomes Cancer; 1998 Jun; 22(2):138-44. PubMed ID: 9598801
[TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
31. [Microsatellite instability in renal cell carcinoma and its mechanisms].
Yu L; Tang D; Ding Y
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):11-3. PubMed ID: 11783059
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer.
Ohue M; Tomita N; Monden T; Miyoshi Y; Ohnishi T; Izawa H; Kawabata Y; Sasaki M; Sekimoto M; Nishisho I; Shiozaki H; Monden M
Int J Cancer; 1996 Oct; 68(2):203-6. PubMed ID: 8900429
[TBL] [Abstract][Full Text] [Related]
33. Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair.
Chung H; Young DJ; Lopez CG; Le TA; Lee JK; Ream-Robinson D; Huang SC; Carethers JM
PLoS One; 2008; 3(10):e3463. PubMed ID: 18941508
[TBL] [Abstract][Full Text] [Related]
34. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
35. Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features.
Tomita S; Deguchi S; Miyaguni T; Muto Y; Tamamoto T; Toda T
Breast Cancer Res Treat; 1999 Jan; 53(1):33-9. PubMed ID: 10206070
[TBL] [Abstract][Full Text] [Related]
36. Proliferation and Cdk4 expression in microsatellite unstable colon cancers with TGFBR2 mutations.
Grady WM; Willis JE; Trobridge P; Romero-Gallo J; Munoz N; Olechnowicz J; Ferguson K; Gautam S; Markowitz SD
Int J Cancer; 2006 Feb; 118(3):600-8. PubMed ID: 16108056
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability and mutations of p53 and TGF-beta RII genes in gastric cancer.
Renault B; Calistri D; Buonsanti G; Nanni O; Amadori D; Ranzani GN
Hum Genet; 1996 Nov; 98(5):601-7. PubMed ID: 8882883
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite instability in patients with multiple primary cancers of the gastrointestinal tract.
Yamashita K; Arimura Y; Kurokawa S; Itoh F; Endo T; Hirata K; Imamura A; Kondo M; Sato T; Imai K
Gut; 2000 Jun; 46(6):790-4. PubMed ID: 10807889
[TBL] [Abstract][Full Text] [Related]
40. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
de Leeuw WJ; Dierssen J; Vasen HF; Wijnen JT; Kenter GG; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse CJ; Morreau H
J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
